The curriculum provides a comprehensive understanding of:
- Health outcomes, including clinical effectiveness, safety, cost, and patient-reported outcomes
- Unique value propositions relevant to payers, providers and regulators
- Data storytelling and visualization to differentiate a pharmaceutical product or service
- Communication tools such as value slide decks, formulary dossiers, abstracts, posters, and manuscripts that are compliant with regulations
- Evidence synthesis through systematic reviews and meta-analyses
- Levels of evidence, including randomized controlled trials, meta-analyses, prospective and retrospective observational studies, and economic modeling
- Types of evidence derived at various phases of drug development and commercialization, from early discovery to post-approval market access
Credit hours:
- Grad certificate: 16 credits. Tuition: 16 x $750 = $12,000
- UF M.S. degree: 32 credits. 32 x $750 = $24,000
- M.S.+MBA program: 52 credits (26 UF + 26 Stetson). Tuition: UF (26 x $750) + Stetson (26 x $1,050) = $46,800UF M.S. degree portion: 32 credits (26 UF credits + 6 Stetson transfer credits)
- Stetson M.B.A. degree portion: 36 credits (26 Stetson credits + 9 UF transfer credits)